ZA983852B - Therapy for constipation - Google Patents

Therapy for constipation

Info

Publication number
ZA983852B
ZA983852B ZA983852A ZA983852A ZA983852B ZA 983852 B ZA983852 B ZA 983852B ZA 983852 A ZA983852 A ZA 983852A ZA 983852 A ZA983852 A ZA 983852A ZA 983852 B ZA983852 B ZA 983852B
Authority
ZA
South Africa
Prior art keywords
constipation
therapy
Prior art date
Application number
ZA983852A
Other languages
English (en)
Inventor
Thomas Julius Borody
Original Assignee
Borody Thomas J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Borody Thomas J filed Critical Borody Thomas J
Publication of ZA983852B publication Critical patent/ZA983852B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA983852A 1997-05-07 1998-05-07 Therapy for constipation ZA983852B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO6653A AUPO665397A0 (en) 1997-05-07 1997-05-07 Novel therapy for constipation

Publications (1)

Publication Number Publication Date
ZA983852B true ZA983852B (en) 1998-11-13

Family

ID=3800945

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA983852A ZA983852B (en) 1997-05-07 1998-05-07 Therapy for constipation

Country Status (13)

Country Link
US (1) US6426338B1 (fr)
EP (1) EP0980246B1 (fr)
AR (1) AR012671A1 (fr)
AT (1) ATE349216T1 (fr)
AU (1) AUPO665397A0 (fr)
CA (1) CA2289717C (fr)
CY (1) CY1107586T1 (fr)
DE (1) DE69836735T2 (fr)
DK (1) DK0980246T3 (fr)
ES (1) ES2279573T3 (fr)
PT (1) PT980246E (fr)
WO (1) WO1998050043A1 (fr)
ZA (1) ZA983852B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001285311B2 (en) 2000-08-29 2005-09-15 Biocon, Ltd Immunoregulatory compounds, derivatives thereof and their use
US6414016B1 (en) 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) * 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
AUPS088702A0 (en) * 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
US7025745B2 (en) * 2002-10-07 2006-04-11 Advanced Cardiovascular Systems, Inc. Method of making a catheter balloon using a tapered mandrel
DE10257824B4 (de) * 2002-12-10 2004-11-11 Kochem, Hans-Günter, Dr. Zusammensetzung zur Schmerzbehandlung, insbesondere zur Behandlung von Gelenkschmerzen
US20050075395A1 (en) * 2003-05-28 2005-04-07 Gary Gordon Continuous dosing regimen
MXPA05012814A (es) * 2003-05-29 2007-01-25 Abbott Lab Regimen de dosificacion continua con n-(2(2 -((4-hidroxifenil) amino)pirid -3-il)-4- metoxibencen -sulfonamida (abt-751).
US20040242649A1 (en) * 2003-05-29 2004-12-02 Hagey Anne E. Extended dosing regimen
EP1720536B1 (fr) * 2004-02-06 2012-04-25 PHARMATEL (R&D) PTY LIMITED as Trustee for the PHARMATEL (R & D) TRUST Utilisation d'aminosalicylates dans le syndrome du colon irritable a predominance diarrheique
US20050191371A1 (en) * 2004-02-12 2005-09-01 Rizo Andres M. Medical composition
JP5009152B2 (ja) * 2004-05-28 2012-08-22 サリックス ファーマシューティカルズ， インコーポレイテッド 放射線誘発性腸炎の予防、処置、および回復
DK1773767T3 (en) 2004-07-07 2016-03-21 Biocon Ltd Synthesis of azo bound in immune regulatory relations
CA2816276A1 (fr) * 2005-08-24 2007-03-01 Salix Pharmaceuticals, Inc. Preparations de balsalazide, leur procede d'obtention et leurs utilisations
US8921344B2 (en) * 2006-11-03 2014-12-30 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
US7452872B2 (en) * 2005-08-24 2008-11-18 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
AU2010312309B2 (en) 2009-10-26 2016-10-06 Thomas Julius Borody Novel enteric combination therapy
DK3564357T3 (da) 2010-02-01 2022-06-20 Rebiotix Inc Bakterieterapi mod clostridium difficile colitis
AU2011245455A1 (en) 2010-04-26 2012-11-15 Salix Pharmaceuticals, Ltd. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males
MX355760B (es) 2010-12-13 2018-04-27 Salix Pharmaceuticals Inc Formulaciones gástricas y colónicas y métodos para elaborar y usar las mismas.
JP2015514715A (ja) * 2012-03-30 2015-05-21 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド コルヒチン製剤、その製造方法および使用方法
DK2877163T3 (en) 2012-07-27 2019-04-15 Redhill Biopharma Ltd FORMULATIONS AND PROCEDURES FOR THE PREPARATION OF FORMS FOR USING GAS DRAINAGE
US9511100B2 (en) 2013-06-05 2016-12-06 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US9782445B2 (en) 2013-06-05 2017-10-10 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US9511099B2 (en) 2013-06-05 2016-12-06 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US10383901B2 (en) 2013-06-05 2019-08-20 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US9694039B2 (en) 2013-06-05 2017-07-04 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
EP4234011A3 (fr) 2013-06-05 2023-09-20 Rebiotix, Inc. Thérapie de restauration du microbiote (mrt), compositions et procédés de fabrication
US10828340B2 (en) 2015-06-09 2020-11-10 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
AU2016274757B2 (en) 2015-06-09 2019-02-07 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
US10905726B2 (en) 2015-06-09 2021-02-02 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
US10799539B2 (en) 2015-06-09 2020-10-13 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5519014A (en) * 1990-10-22 1996-05-21 Borody; Thomas J. Treatment of non-inflammatory and non-infectious bowel disorders
ES2213139T5 (es) * 1990-10-22 2011-03-18 Centre For Digestive Diseases Pty Ltd Tratamiento de trastornos intestinales no inflamatorios.

Also Published As

Publication number Publication date
EP0980246B1 (fr) 2006-12-27
DE69836735D1 (de) 2007-02-08
CA2289717A1 (fr) 1998-11-12
EP0980246A1 (fr) 2000-02-23
CY1107586T1 (el) 2013-03-13
DK0980246T3 (da) 2007-05-07
EP0980246A4 (fr) 2004-04-14
AUPO665397A0 (en) 1997-05-29
ES2279573T3 (es) 2007-08-16
AR012671A1 (es) 2000-11-08
WO1998050043A1 (fr) 1998-11-12
US6426338B1 (en) 2002-07-30
ATE349216T1 (de) 2007-01-15
DE69836735T2 (de) 2007-10-11
PT980246E (pt) 2007-02-28
CA2289717C (fr) 2009-02-03

Similar Documents

Publication Publication Date Title
ZA983852B (en) Therapy for constipation
EG24678A (en) Combination therapy
ZA983176B (en) Therapeutic compounds
GB9725782D0 (en) Therapeutic agents
GB9708484D0 (en) Therapeutic agents
GB9708945D0 (en) Therapeutic agents
GB9704948D0 (en) Therapeutic agents
GB9702524D0 (en) Therapeutic agents
IL127306A0 (en) Combination therapy
GB9711753D0 (en) Therapeutic agents
GB9715977D0 (en) Therapeutic agents
GB9711114D0 (en) Therapeutic agents
HUP0300615A3 (en) Therapeutic agents
GB9700939D0 (en) Therapy
ZA98968B (en) Therapeutic agents
GB9700555D0 (en) Therapeutic agents
GB9716345D0 (en) Therapeutic compounds
GB9716347D0 (en) Therapeutic compounds
GB9716344D0 (en) Therapeutic compounds
GB9716463D0 (en) Therapeutic agents
GB9708698D0 (en) Materials for therapy
GB9716457D0 (en) Therapeutic agents
GB9704885D0 (en) Therapy
GB9716111D0 (en) Therapeutic compounds
GB9705401D0 (en) Therapeutic compounds